Review of chemoprevention options for familial adenomatous polyposis

This review looked at various chemopreventive strategies for familial adenomatous polyposis. The strategies included nonsteroidal anti-inflammatory drugs, prostaglandin E2 receptor antagonists, phytoestrogens, targeted pathway inhibitors, gut microbiota modulation, and natural products. The study did not report a specific sample size or population details. Because the review did not report primary or secondary outcomes, specific main results were not available in the provided information. There were no reported adverse events, serious adverse events, discontinuations, or issues with tolerability. The review did not report funding sources or conflicts of interest. Readers should note that this is a review and the specific findings regarding effectiveness were not detailed in the source text. The practice relevance and certainty of the evidence were not reported. This information is provided for general awareness and does not constitute medical advice. Patients should discuss prevention options with their healthcare providers.